MedTrace Logo

Enhancing Health Literacy Through AI-Powered Chatbot: a Randomized Controlled Trial

NCT06702423 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 844

Last updated 2024-11-25

No results posted yet for this study

Summary

The goal of this study is to learn if an innovative digital artificial intelligence (AI)-based communication tool works to enhance health literacy among Japanese caregivers regarding Human Papillomavirus (HPV) vaccination.

Participants will:

* Answer a pre-intervention survey, get information regarding HPV vaccination from an AI-based chatbot or leaflet, and answer a post-intervention survey.
* Continue interacting with the chatbot or leaflet for two weeks.
* Answer a follow-up survey.

Conditions

  • Healthy

Interventions

BEHAVIORAL

AI-based chatbot

A tailored Japanese HPV vaccination chatbot.

BEHAVIORAL

Leaflet

A publicly accessible HPV vaccination leaflet prepared by the Ministry of Health, Labour, and Welfare.

Sponsors & Collaborators

  • London School of Hygiene and Tropical Medicine

    collaborator OTHER

  • Nagasaki University

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Leesa Lin, PhD · London School of Hygiene and Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-25
Primary Completion
2024-12-15
Completion
2025-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06702423 on ClinicalTrials.gov